NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Genome British Columbia

Genome British Columbia

Vancouver, British Columbiagenomebc.ca

Overview

Genome British Columbia is a not-for-profit organization that invests in and supports world-class genomics research and innovation to address challenges and grow the life sciences sectors in British Columbia. It focuses on key areas such as health, forestry, fisheries, aquaculture, agrifood, energy, mining, and the environment. The organization acts as a catalyst, partnering with government, academia, and industry to translate research into applications that generate social and economic benefits. It also works to integrate genomics into society through public engagement and educational initiatives.

Portfolio Companies

13

Investments

Genome British Columbia investments
CompanyDateStageLead
Integrated NanotherapeuticsMar 2026GrantCo-investor
Renaissance BioScience Corp.Feb 2026GrantLead
Arbutus Medical Inc.Feb 2026Growth EquityCo-investor
Maia FarmsSep 2025GrantLead
eDNA ExplorerJun 2025GrantLead

Sector & Stage Mix

Industry, funding stage, and valuation band breakdowns.

Premium
SeedSeries ASeries BGrowth

Unlock portfolio analytics

Sign up to view full sector, stage, and valuation breakdowns for this investor.

Investment Activity

Yearly cadence, pace, and funding raised over time.

Premium
2021
2022
2023
2024
2025
2026

Unlock portfolio analytics

Sign up to explore yearly investment trends and funding raised over time.

FAQ

Firmographic Details

HeadquartersVancouver, British Columbia
Year FoundedN/A

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.